Insiders Updates
Investing in Acrivon Therapeutics Inc (ACRV) Is Getting More Attractive
Acrivon Therapeutics Inc’s filing revealed that its 10% Owner PERCEPTIVE ADVISORS LLC acquired Company’s shares for reported $20.0 million on
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.